PURPOSE: To discover drugs lowering PrP(Sc) in prion-infected cultured neuronal cells that achieve high concentrations in brain to test in mouse models of prion disease and then treat people with these fatal diseases. METHODS: We tested 2-AMT analogs for EC50 and PK after a 40 mg/kg single dose and 40-210 mg/kg/day doses for 3 days. We calculated plasma and brain AUC, ratio of AUC/EC50 after dosing. We reasoned that compounds with high AUC/EC50 ratios should be good candidates going forward. RESULTS: We evaluated 27 2-AMTs in single-dose and 10 in 3-day PK studies, of which IND24 and IND81 were selected for testing in mouse models of prion disease. They had high concentrations in brain after oral dosing. Absolute bioavailability ranged from 27-40%. AUC/EC50 ratios after 3 days were >100 (total) and 48-113 (unbound). Stability in liver microsomes ranged from 30->60 min. Ring hydroxylated metabolites were observed in microsomes. Neither was a substrate for the MDR1 transporter. CONCLUSIONS: IND24 and IND81 are active in vitro and show high AUC/EC50 ratios (total and unbound) in plasma and brain. These will be evaluated in mouse models of prion disease.
PURPOSE: To discover drugs lowering PrP(Sc) in prion-infected cultured neuronal cells that achieve high concentrations in brain to test in mouse models of prion disease and then treat people with these fatal diseases. METHODS: We tested 2-AMT analogs for EC50 and PK after a 40 mg/kg single dose and 40-210 mg/kg/day doses for 3 days. We calculated plasma and brain AUC, ratio of AUC/EC50 after dosing. We reasoned that compounds with high AUC/EC50 ratios should be good candidates going forward. RESULTS: We evaluated 27 2-AMTs in single-dose and 10 in 3-day PK studies, of which IND24 and IND81 were selected for testing in mouse models of prion disease. They had high concentrations in brain after oral dosing. Absolute bioavailability ranged from 27-40%. AUC/EC50 ratios after 3 days were >100 (total) and 48-113 (unbound). Stability in liver microsomes ranged from 30->60 min. Ring hydroxylated metabolites were observed in microsomes. Neither was a substrate for the MDR1 transporter. CONCLUSIONS:IND24 and IND81 are active in vitro and show high AUC/EC50 ratios (total and unbound) in plasma and brain. These will be evaluated in mouse models of prion disease.
Authors: Aneta T Petkova; Richard D Leapman; Zhihong Guo; Wai-Ming Yau; Mark P Mattson; Robert Tycko Journal: Science Date: 2005-01-14 Impact factor: 47.728
Authors: K Hsiao; H F Baker; T J Crow; M Poulter; F Owen; J D Terwilliger; D Westaway; J Ott; S B Prusiner Journal: Nature Date: 1989-03-23 Impact factor: 49.962
Authors: Duo Lu; Kurt Giles; Zhe Li; Satish Rao; Elena Dolghih; Joel R Gever; Michal Geva; Manuel L Elepano; Abby Oehler; Clifford Bryant; Adam R Renslo; Matthew P Jacobson; Stephen J Dearmond; B Michael Silber; Stanley B Prusiner Journal: J Pharmacol Exp Ther Date: 2013-08-21 Impact factor: 4.030
Authors: David B Berry; Duo Lu; Michal Geva; Joel C Watts; Sumita Bhardwaj; Abby Oehler; Adam R Renslo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles Journal: Proc Natl Acad Sci U S A Date: 2013-10-15 Impact factor: 11.205
Authors: Simon Mead; Matthew Burnell; Jessica Lowe; Andrew Thompson; Ana Lukic; Marie-Claire Porter; Christopher Carswell; Diego Kaski; Janna Kenny; Tze How Mok; Nina Bjurstrom; Edit Franko; Michele Gorham; Ronald Druyeh; Jonathan D F Wadsworth; Zane Jaunmuktane; Sebastian Brandner; Harpreet Hyare; Peter Rudge; A Sarah Walker; John Collinge Journal: JAMA Neurol Date: 2016-04 Impact factor: 18.302
Authors: David Berry; Kurt Giles; Abby Oehler; Sumita Bhardwaj; Stephen J DeArmond; Stanley B Prusiner Journal: J Infect Dis Date: 2015-07-15 Impact factor: 5.226
Authors: Kurt Giles; David B Berry; Carlo Condello; Ronald C Hawley; Alejandra Gallardo-Godoy; Clifford Bryant; Abby Oehler; Manuel Elepano; Sumita Bhardwaj; Smita Patel; B Michael Silber; Shenheng Guan; Stephen J DeArmond; Adam R Renslo; Stanley B Prusiner Journal: J Pharmacol Exp Ther Date: 2015-07-29 Impact factor: 4.030
Authors: Zhe Li; B Michael Silber; Satish Rao; Joel R Gever; Clifford Bryant; Alejandra Gallardo-Godoy; Elena Dolghih; Kartika Widjaja; Manuel Elepano; Matthew P Jacobson; Stanley B Prusiner; Adam R Renslo Journal: ChemMedChem Date: 2013-03-18 Impact factor: 3.466
Authors: Kurt Giles; David B Berry; Carlo Condello; Brittany N Dugger; Zhe Li; Abby Oehler; Sumita Bhardwaj; Manuel Elepano; Shenheng Guan; B Michael Silber; Steven H Olson; Stanley B Prusiner Journal: J Pharmacol Exp Ther Date: 2016-06-17 Impact factor: 4.030
Authors: B Michael Silber; Joel R Gever; Zhe Li; Alejandra Gallardo-Godoy; Adam R Renslo; Kartika Widjaja; John J Irwin; Satish Rao; Matthew P Jacobson; Sina Ghaemmaghami; Stanley B Prusiner Journal: Bioorg Med Chem Date: 2013-09-18 Impact factor: 3.641